Related Experiment Video

Updated: Aug 25, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Host factors and failure of interferon-alpha treatment in hepatitis C virus

Bin Gao1, Feng Hong, Svetlana Radaeva

  • 1Section on Liver Biology, Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. bgao@mail.nih.gov

Hepatology (Baltimore, Md.)
|April 2, 2004
PubMed

Insights

Host factors significantly impact treatment failure in chronic hepatitis C virus (HCV) patients receiving interferon-alpha (IFN-alpha). This review explores these host factors and proposes strategies to improve IFN-alpha therapy effectiveness.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis C virus (HCV) infection poses a significant clinical challenge.
  • Interferon-alpha (IFN-alpha) therapy failure is common in HCV patients.
  • Both viral and host factors contribute to IFN-alpha treatment resistance.

Purpose of the Study:

  • To review the role of host factors in IFN-alpha treatment failure for chronic hepatitis C.
  • To elucidate the mechanisms underlying host-mediated resistance to IFN-alpha therapy.
  • To propose novel therapeutic strategies to overcome treatment failure.

Main Methods:

  • Literature review of studies investigating host factors in HCV and IFN-alpha response.
  • Analysis of mechanisms by which host factors influence IFN-alpha efficacy.
  • Synthesis of current knowledge on host-driven IFN-alpha unresponsiveness.

Main Results:

  • Evidence suggests host genetic and cellular factors play a crucial role in IFN-alpha treatment outcomes.
  • Specific host pathways have been identified that can either enhance or inhibit the antiviral effects of IFN-alpha.
  • Understanding these host factors is critical for predicting treatment response.

Conclusions:

  • Host factors are critical determinants of interferon-alpha treatment success in chronic hepatitis C.
  • Targeting host-specific pathways may overcome viral resistance and improve therapeutic outcomes.
  • Further research into host-pathogen interactions is essential for developing personalized HCV therapies.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...